Tailoring Medulloblastoma Treatment Through Genomics: Making a Change, One Subgroup at a Time

Abstract excerpt

After more than a decade of genomic studies in medulloblastoma, the time has come to capitalize on the knowledge gained and use it to directly improve patient care. Although metastatic and relapsed disease remain poorly understood, much has changed in how we define medulloblastoma, and it has become evident that with conventional therapies, specific groups of patients are currently under- or overtreated. In this...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Chromatin Remodeling and Cancer
• Share to Glioma Diagnosis and Treatment